Trial Profile
Post marketing study of sofosbuvir and ledipasvir for genotype 1 hepatitis C virus infection
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 30 Jan 2019
Price :
$35
*
At a glance
- Drugs Ledipasvir/sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 23 Jan 2019 Status changed from active, no longer recruiting to completed.
- 21 Jan 2018 Status changed from recruiting to active, no longer recruiting.
- 26 Jul 2016 New trial record